MedTrace Logo

A Study of Bupivacaine Liposome Injection in Local Analgesia of Pediatric Patients

NCT06344091 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 232

Last updated 2025-10-02

No results posted yet for this study

Summary

The study is being conducted to evaluate the safety and efficacy of bupivacaine liposome injection for local infiltration analgesia in pediatric orthopedic surgery in the real world.

Conditions

  • Local Analgesia Via Infiltration

Interventions

DRUG

Bupivacaine Liposome Injection

Bupivacaine Liposome Injection 4 mg/kg (up to a maximum of 266 mg)

Sponsors & Collaborators

  • Jiangsu HengRui Medicine Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-21
Primary Completion
2026-09-28
Completion
2026-10-12

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06344091 on ClinicalTrials.gov